Natraj Proteins Limited (BOM:530119)
India · Delayed Price · Currency is INR 35.02
0.00 (0.00%)
At close: Nov 13, 2026
Natraj Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 972.65 | 1,011 | 1,178 | 1,937 | 1,436 | 1,447 |
| 972.65 | 1,011 | 1,178 | 1,937 | 1,436 | 1,447 | |
Revenue Growth | -11.53% | -14.15% | -39.20% | 34.91% | -0.77% | -1.03% |
Cost of Revenue | 833.43 | 921.69 | 1,099 | 1,945 | 1,334 | 1,232 |
Gross Profit | 139.22 | 89.53 | 78.78 | -7.31 | 101.89 | 215.07 |
Selling, General & Admin | 11.5 | 11.54 | 13.14 | 13.03 | 11.85 | 13.94 |
Other Operating Expenses | 36.09 | 41.91 | 54.49 | 73.32 | 59 | 59.52 |
Operating Expenses | 51.93 | 57.3 | 71.08 | 90.83 | 75.12 | 77.42 |
Operating Income | 87.29 | 32.23 | 7.7 | -98.13 | 26.77 | 137.65 |
Interest Expense | -24.5 | -22.83 | -22.66 | -27.11 | -16.97 | -9.16 |
Interest & Investment Income | 2.35 | 2.35 | 2.3 | 2.03 | 2.06 | 2.1 |
Other Non Operating Income (Expenses) | -1.04 | -0.67 | 0.6 | -2.37 | -1.76 | -1.2 |
EBT Excluding Unusual Items | 64.11 | 11.07 | -12.07 | -125.58 | 10.1 | 129.39 |
Gain (Loss) on Sale of Investments | -0.01 | -0.01 | 0.31 | 0.96 | 0.08 | 0.17 |
Pretax Income | 64.09 | 11.06 | -11.77 | -124.63 | 10.18 | 129.56 |
Income Tax Expense | -0.41 | -0.29 | 2.86 | 0.56 | 3.05 | 35.94 |
Net Income | 64.5 | 11.35 | -14.63 | -125.19 | 7.13 | 93.62 |
Net Income to Common | 64.5 | 11.35 | -14.63 | -125.19 | 7.13 | 93.62 |
Net Income Growth | - | - | - | - | -92.38% | 2279.21% |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Change | 0.04% | - | - | - | - | - |
EPS (Basic) | 17.21 | 3.03 | -3.90 | -33.41 | 1.90 | 24.99 |
EPS (Diluted) | 17.21 | 3.03 | -3.90 | -33.41 | 1.90 | 24.99 |
EPS Growth | - | - | - | - | -92.40% | 2279.61% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -56.21 | -138.5 | 209.11 | -56.95 | 6.54 | 40.46 |
Free Cash Flow Per Share | -15.00 | -36.96 | 55.81 | -15.20 | 1.75 | 10.80 |
Gross Margin | 14.31% | 8.85% | 6.69% | -0.38% | 7.09% | 14.86% |
Operating Margin | 8.97% | 3.19% | 0.65% | -5.07% | 1.86% | 9.51% |
Profit Margin | 6.63% | 1.12% | -1.24% | -6.46% | 0.50% | 6.47% |
Free Cash Flow Margin | -5.78% | -13.70% | 17.75% | -2.94% | 0.46% | 2.80% |
EBITDA | 91.59 | 36.03 | 11.07 | -93.74 | 31 | 141.61 |
EBITDA Margin | 9.42% | 3.56% | 0.94% | -4.84% | 2.16% | 9.79% |
D&A For EBITDA | 4.29 | 3.8 | 3.37 | 4.39 | 4.23 | 3.96 |
EBIT | 87.29 | 32.23 | 7.7 | -98.13 | 26.77 | 137.65 |
EBIT Margin | 8.97% | 3.19% | 0.65% | -5.07% | 1.86% | 9.51% |
Effective Tax Rate | - | - | - | - | 29.96% | 27.74% |
Revenue as Reported | 974.97 | 1,014 | 1,183 | 1,940 | 1,437 | 1,450 |
Advertising Expenses | - | - | - | - | 0.01 | 0.01 |